HOME >> MEDICINE >> NEWS
Pitt researchers find gender differences in the mental health care of children

PITTSBURGH, May 13 Mental health care of children has a gender-based difference in the primary care setting, according to an article in the May issue of the Archives of Pediatrics & Adolescent Medicine, a member of the JAMA family of journals.

We found substantial disparities in the way primary care clinicians identified boys and girls with similar parent-reported symptoms. These disparities in the identification of mental health problems produce differences in their treatment, said William Gardner, Ph.D., professor of medicine and psychiatry, University of Pittsburgh School of Medicine.

Primary care clinicians (PCCs) were more likely to identify boys using the term my patient. The researchers suggest this may be the case because boys were more likely to be seen by male clinicians, who are more likely to work in settings that support continuity of care. According to the researchers, clinicians who saw their own patients were substantially more likely to find and treat mental health problems in those patients.

The researchers found that compared with girls, visits by boys with similar parent-reported symptoms were more likely to be perceived by the PCC as mental health related. PCCs were more likely to find and treat mental health problems during visits perceived as mental health visits.

This may have occurred because parents were more likely to label a boys behavior as a mental health problem. Alternatively, whereas parents may have labeled boys and girls behavior similarly, they may have been more likely to seek medical care for such behavior when exhibited by a boy. Finally, because we relied on the PCCs report, it is possible that the clinician was more likely to label the visit as mental health related when the patient was a boy, said Dr. Gardner.

Boys with parent-reported symptoms similar to girls symptoms were more likely to be identified as having attention-deficit/hyperactivity disorder problems or other behavior or
'"/>

Contact: Jocelyn Uhl
412-624-2607
University of Pittsburgh Medical Center
14-May-2002


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 ... accelerating throughout 2013 across all industries as cash rich ... Despite the differences across industries, all M&A transactions have ... rigorous due diligence to verify the history and quality ... carefully considered. , But when due diligence involves ...
(Date:6/18/2013)... 19, 2013 Consumer injury attorney Michael ... law firms have launched a new website for people ... dialysis. The website is http://www.DialysisLawsuitAttorneys.com . , "My ... begin offering legal services to people who may have ... NaturaLyte, or who may have suffered injuries due to ...
(Date:6/18/2013)... Exposed Skin Care has finally been released ... of all ages finally achieve the clear, beautiful skin they ... new acne clearing system combines the power of science and ... from forming. , After a quick review ... some of the most effective available on the market to ...
(Date:6/18/2013)... 2013 Parker Waichman LLP, a national ... injured by dangerous drugs and medical devices, has filed ... alleges that she was injured by transvaginal mesh ... in the U.S. District Court for the Southern District ... multidistrict litigation entitled In Re: American Medical Systems, Inc., ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 Cheap ... tickets for the tournament which gets underway in July. ... savings on any CONCACAF ticket order. , The ... and cranny of the globe.    In fact, the hype of the ... Its popularity also trickled down the veins of fans ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 2Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 4Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3
(Date:6/18/2013)... June 18, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, announces that its Market ... Middle East and ... the challenges and opportunities to gaining and maintaining ... comprising 24 countries. The countries covered by Market ...
(Date:6/18/2013)... New-generation electronic designs are focused on ... Simultaneously, circuitry is increasing the number of functions ... it performs at. Connecting cables from the active ... such as cameras or detectors, must be small, ... include custom cable designs for high-quality signal and ...
(Date:6/18/2013)... Australia And EMERYVILLE, Calif. ... Pharmaceuticals, Inc. presented final results today from a ... extended release) capsules demonstrating a statistically significant improvement ... from baseline at week 8 versus placebo in ... Adamas, investigational extended-release formulation of amantadine intended for ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
Cached News: